0001562180-24-005843.txt : 20240725
0001562180-24-005843.hdr.sgml : 20240725
20240725193304
ACCESSION NUMBER: 0001562180-24-005843
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20240724
FILED AS OF DATE: 20240725
DATE AS OF CHANGE: 20240725
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: COHEN RAYMOND W
CENTRAL INDEX KEY: 0001258288
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38721
FILM NUMBER: 241143282
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Axonics, Inc.
CENTRAL INDEX KEY: 0001603756
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
ORGANIZATION NAME: 08 Industrial Applications and Services
IRS NUMBER: 454744083
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 26 TECHNOLOGY DRIVE
CITY: IRVINE
STATE: CA
ZIP: 92618
BUSINESS PHONE: 949-396-6322
MAIL ADDRESS:
STREET 1: 26 TECHNOLOGY DRIVE
CITY: IRVINE
STATE: CA
ZIP: 92618
FORMER COMPANY:
FORMER CONFORMED NAME: Axonics Modulation Technologies, Inc.
DATE OF NAME CHANGE: 20140326
4
1
primarydocument.xml
PRIMARY DOCUMENT
X0508
4
2024-07-24
false
0001603756
Axonics, Inc.
AXNX
0001258288
COHEN RAYMOND W
26 TECHNOLOGY DRIVE
IRVINE
CA
92618
true
true
false
false
Chief Executive Officer
false
Common Stock
2024-07-24
4
M
false
25771.00
14.19
A
214606.00
D
Common Stock
2024-07-24
4
M
false
78125.00
25.82
A
292731.00
D
Stock Option (Right to Buy)
25.82
2024-07-24
4
M
false
78125.00
0.00
D
2029-12-12
Common Stock
78125.00
0.00
D
Stock Option (Right to Buy)
14.19
2024-07-24
4
M
false
25771.00
0.00
D
2029-01-30
Common Stock
25771.00
196451.00
D
These options were granted on December 12, 2019 and are fully vested.
These options were granted on January 30, 2019 and are fully vested.
Kari L. Keese, as Attorney-in-fact for Raymond W Cohen
2024-07-25
EX-24
2
rcohennpoa.txt
POA
POWER OF ATTORNEY
Know all by these presents, that the undersigned hereby constitutes
and appoints each of Kari L. Keese, and Michael A. Hedge, signing singly,
as the undersigned's true and lawful attorney-in-fact to:
(1) execute for and on behalf of the undersigned, in the
undersigned's capacity as an officer and/or director of
Axonics, Inc. (the "Company"), a Form ID and Forms 3, 4 and 5
in accordance with Section 16(a) of the Securities Exchange
Act of 1934, as amended, and the rules thereunder;
(2) do and perform any and all acts for and on behalf of the
undersigned which may be necessary or desirable to complete
and execute any such Form ID, 3, 4 or 5 and file such form
with the United States Securities and Exchange Commission and
any stock exchange or similar authority or organization; and
(3) take any other action of any type whatsoever in connection
with the foregoing which, in the opinion of such attorney-in-
fact, may be of benefit to, in the best interest of, or
legally required by, the undersigned, it being understood that
the documents executed by such attorney-in-fact on behalf of
the undersigned pursuant to this Power of Attorney shall be in
such form and shall contain such terms and conditions as such
attorney-in-fact may approve in such attorney-in-fact's
discretion.
The undersigned hereby grants to each such attorney-in-fact full
power and authority to do and perform any and every act and thing
whatsoever requisite, necessary or proper to be done in the exercise of
any of the rights and powers herein granted, as fully to all intents and
purposes as the undersigned might or could do if personally present, with
full power of substitution or revocation, hereby ratifying and confirming
all that such attorney-in-fact, or such attorney-in-fact's substitute or
substitutes, shall lawfully do or cause to be done by virtue of this
power of attorney and the rights and powers herein granted. The
undersigned acknowledges that the foregoing attorneys-in-fact, in serving
in such capacity at the request of the undersigned, are not assuming, nor
is the Company assuming, any of the undersigned's responsibilities to
comply with Section 16 of the Securities Exchange Act of 1934, as
amended.
This Power of Attorney shall remain in full force and effect until
the undersigned is no longer required to file Forms 3, 4 and 5 with
respect to the undersigned's holdings of and transactions in securities
issued by the Company, unless earlier revoked by the undersigned in a
signed writing delivered to the foregoing attorneys-in-fact.
IN WITNESS WHEREOF, the undersigned has caused this Power of
Attorney to be executed as of this 4th day of October 2023.
Raymond Cohen
/s/ Raymond Cohen
676847.1\16367.0007
CORP:67609_1|379|A9324.00000
1
DOCSOC\701736v1\16367.0008
501859284 v1